COASTAL PHYSICIAN GROUP INC
10-Q, 1996-06-10
HELP SUPPLY SERVICES
Previous: CALLOWAYS NURSERY INC, 8-K, 1996-06-10
Next: IDEC PHARMACEUTICALS CORP / CA, 424B4, 1996-06-10



                                
                          UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                      WASHINGTON, DC 20549
                                
                            Form 10-Q
                                
  {X}  Quarterly Report Pursuant to Section 13 or 15(d) of the
                 Securities Exchange Act of 1934

          For the quarterly period ended MARCH 31, 1996

                               OR
                                
 { }   Transition Report Pursuant to Section 13 or 15(d) of the
                 Securities Exchange Act of 1934

       For the transition period from                   to


                Commission File Number 001-13460

                  COASTAL PHYSICIAN GROUP, INC.
     (Exact name of registrant as specified in its charter)
                                
                                
                 DELAWARE                 56-1379244
     (State or other jurisdiction of         (IRS Employer
     incorporation or organization)          Identification No.)

         2828 CROASDAILE DRIVE, DURHAM, NC         27705
     (Address of principal executive offices)          (Zip Code)

                              (919) 383-0355
       (Registrant's telephone number including area code)

                                      NONE
 (Former name, former address and former fiscal year, if changed
                       since last report)
                                
Indicate by check mark whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days.

                     { } Yes         {X} No

As of April 30, 1996 there were outstanding 23,835,665 shares of
common stock, par value $.01 per share.

                  COASTAL PHYSICIAN GROUP, INC.
                              INDEX
                                
                                
                                
PART I -  FINANCIAL INFORMATION

Item 1.   Financial Statements
          Consolidated Balance Sheets
          Unaudited Consolidated Statements of Operations
          Unaudited Consolidated Condensed Statement
          of Cash Flows
          Notes to Consolidated Financial Statements (Unaudited)
Item 2.   Management's Discussion and Analysis of
          Financial Condition and Results of Operations

PART II - OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K

SIGNATURES




                 COASTAL PHYSICIAN GROUP, INC.
                  Consolidated Balance Sheets
     (In thousands of U.S. dollars, except per share data)

                                         March 31,     December
                                            1996          31,
                                                         1995
                                         (unaudite    
                                             d)
                 Assets                               
Current assets:                                       
 Cash and cash equivalents                    19,314         8,147
 Marketable securities                         8,476         9,303
 Trade accounts receivable, net              150,779       149,891
 Accounts receivable, other                   17,638        11,315
 Notes receivable from shareholders            1,791         1,879
 Refundable income taxes                         664        12,804
 Prepaid expenses and other current            5,759         3,882
assets
 Deferred income taxes                         4,265         4,265
      Total current assets                   208,686       201,486
Property and equipment, at cost, less                             
    accumulated depreciation                 32,008        33,441
Excess of cost over fair value of net                             
      assets acquired, net                   53,188        53,836
Deferred income taxes                          2,327         2,244
Other assets                                  19,013        22,050
      Total assets                           315,222       313,057
                                                                 
  Liabilities and Shareholders' Equity                           
Current liabilities:                                              
 Current maturities and other short-term                          
      borrowings                              6,594         5,210
 Accounts payable                             19,588        19,600
 Accrued physicians fees and medical          37,100        38,468
costs
 Accrued expenses                             23,220        26,138
     Total current liabilities               86,502        89,416
Long-term debt, excluding current             93,773        77,270
maturities
      Total liabilities                      180,275       166,686
Shareholders' equity:                                             
 Preferred stock $.01 par value; shares                           
      authorized 10,000; none issued or                          
      outstanding                               ---           ---
 Common stock $.01 par value; shares                              
      authorized 100,000; shares issued                          
      and outstanding 23,712 and                                 
 23,754,   respectively                         238           238
 Additional paid-in capital                  142,618       142,345
 Retained earnings (accumulated deficit)     (8,104)         3,626
 Unrealized appreciation of available-                            
     for-sale securities                        195           162
      Total shareholders' equity             134,947       146,371
      Total liabilities and shareholders'                         
       equity                               315,222       313,057

  See accompanying notes to consolidated financial statements.

                 COASTAL PHYSICIAN GROUP, INC.
        Unaudited Consolidated Statements of Operations
     (In thousands of U.S. dollars, except per share data)

                                           Three months ended
                                                March 31,
                                           1996          1995
                                                      
Operating revenue, net                       152,734       207,859
                                                                  
Costs and expenses:                                               
                                                                  
 Physician and other provider services       113,565       144,164
 Medical support services                     24,177        30,979
 Selling, general and administrative          24,901        21,336
      Total costs and expenses               162,643       196,479
                                                                  
Operating income (loss)                      (9,909)        11,380
                                                                  
Other income (expense):                                           
 Interest expense                            (2,103)       (1,165)
 Interest income                                 125           193
 Other, net                                      157            21
      Total other expense                    (1,821)         (951)
                                                                  
Income (loss) before income taxes           (11,730)        10,429
                                                                  
Provision for income taxes                       ---         4,062
                                                                  
Net income (loss)                           (11,730)         6,367
                                                                  
Net income (loss) per share                   (0.49)          0.27
                                                                  
Weighted average number of shares                                 
 outstanding                                 23,791        23,539

  See accompanying notes to consolidated financial statements.

                 COASTAL PHYSICIAN GROUP, INC.
   Unaudited Consolidated Condensed Statements of Cash Flows
                 (In thousands of U.S. dollars)

                                           Three months ended
                                                March 31,
                                           1996          1995
                                                                  
Net cash (used in) provided by                                    
 operating activities                      (10,728)         4,868
                                                                  
Cash flows from investing activities:                             
 Sales (purchases) of marketable                                  
    securities and investments, net           4,873       (1,511)
 Purchases of property and equipment,          (782)      (11,659)
    net
 Acquisition of subsidiaries, net of                              
    cash acquired                               ---      (12,412)
 Disposition of subsidiaries, net of                              
    cash disposed                             (322)           ---
          Net cash provided by (used                              
          in)investing activities             3,769      (25,582)
                                                                  
Cash flows from financing activities:                             
 Repayments of long-term debt                (1,290)         (676)
 Borrowings on long-term debt                 19,165        18,478
 Net proceeds from issuances of common                            
    stock                                       251           636
          Net cash provided by                                    
          financing activities               18,126        18,438
                                                                  
          Net increase (decrease) in                              
        cash and cash equivalents            11,167       (2,276)
                                                                  
Cash and cash equivalents at beginning                            
    of period                                 8,147        14,286
Cash and cash equivalents at end of                               
    period                                   19,314        12,010
                                                                  
                                                                  
Supplemental disclosures of cash flow                             
      information:
      Cash payments (refunds) during                              
    the period for:
             Interest                          1,673         1,210
             Income taxes                   (12,155)       (4,235)
                                                                  
                                                                  

  See accompanying notes to consolidated financial statements.
                  COASTAL PHYSICIAN GROUP, INC.
           NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                           (UNAUDITED)
                                

(1)   BASIS OF PRESENTATION

The  accompanying  consolidated financial statements  of  Coastal
Physician Group, Inc. (the "Company") are unaudited and,  in  the
opinion  of  management, include all adjustments,  consisting  of
only normal recurring adjustments, which are necessary for a fair
presentation.   The  unaudited consolidated financial  statements
should   be  read  in  conjunction  with  the  Company's  audited
consolidated financial statements and the notes thereto  included
in  the  Company's Annual Report on Form 10-K for the year  ended
December  31,  1995.  Operating results for the  interim  periods
presented are not necessarily indicative of the results that  may
be expected for the fiscal year ending December 31, 1996.

(2)   COMMITMENTS AND CONTINGENCIES

The Company procures professional liability insurance coverage on
behalf of its operating subsidiaries on a claims-made basis.  The
insurance  contracts  specify that  coverage  is  available  only
during  the term of each insurance contract.  Management  of  the
Company  intends  to  renew  the  existing  claims-made  policies
annually  and  expects to be able to obtain such coverage.   When
coverage  is  not renewed, the subsidiary companies  purchase  an
extended  reporting  period endorsement to  provide  professional
liability  coverage for losses incurred prior  to,  but  reported
subsequent to, the termination of the claims-made policies.

The  Company  and  its independent contractor  physicians  obtain
their  professional  liability insurance coverages  from  various
insurance  carriers.  Several insurance carriers  who  underwrote
certain  portions  of  these coverages from  1986  to  1992  have
announced  a  moratorium  on  the  payment  of  claims  or   have
established  plans to pay claims in the future  based  on  formal
plans  of  arrangement.  As of March 31, 1996,  the  Company  had
approximately  $2,800,000  in  receivables  relating  to  certain
claims  for  which reimbursement is still pending and anticipates
that substantially all of these amounts will be collected in full
from  the  carriers.  The Company includes these receivables   in
other assets in the accompanying consolidated balance sheets.

The  Company  is  a  defendant  in certain  lawsuits  by  certain
shareholders with respect to representations concerning the

                  COASTAL PHYSICIAN GROUP, INC.
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                           (UNAUDITED)


Company's  operations and prospects.  The Company believes  these
lawsuits  are  without  merit, intends to vigorously  defend  its
position, and does not expect such litigation to have a  material
adverse effect on the Company's financial position or results  of
operations.

An  operating  subsidiary of the Company  is  a  defendant  in  a
lawsuit  regarding  billings  to  and  collections  from  certain
Federal  government  insurance programs.   The  Company  and  its
counsel are reviewing this lawsuit and, at this time, exposure to
the Company is indeterminable.

In  addition,  as  of March 31, 1996, certain  of  the  Company's
operating subsidiaries were defendants in various malpractice and
other  lawsuits.  Management believes that these lawsuits  should
not   result   in   judgments  which,  after   consideration   of
professional liability and general insurance coverage, would have
a material  adverse effect on the Company's financial position or
results of operations.

(3) SENIOR CREDIT FACILITY

During the first quarter of 1996, the Company had a senior credit
facility  (  the  "Senior  Credit  Facility")  with  a  group  of
commercial  lenders  pursuant to which the Company  could  borrow
(prior  to the restructuring described below) up to $161,750,000,
consisting of a $50,000,000 three-year revolving credit  facility
to  be  used  for working capital purposes (the "Working  Capital
Facility")  and  a  $111,750,000  seven-year  reducing  revolving
credit  facility  to be used for acquisitions  (the  "Acquisition
Facility").   Borrowings outstanding as of March 31,  1996  under
these facilities were $45,875,000 and $36,625,000, respectively.

As  of  March  31,  1996,  due primarily to  the  operating  loss
generated  for  the  three months ended December  31,  1995,  the
Company was in violation of certain financial covenants under the
Senior Credit Facility.  A number of temporary waivers of default
and  any  resulting events of default have been received  by  the
Company,  the latest through May 31, 1996.  On May 29, 1996,  the
Company entered into new credit agreements which restructured the
existing  Acquisition and Working Capital facilities and  provide
the Company up to $40,000,000 of additional borrowing
                                
                  COASTAL PHYSICIAN GROUP, INC.
     NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
                           (UNAUDITED)


availability  under  a  new facility (the  "Overline  Facility").
Under  the  terms  of  the  restructured existing  Senior  Credit
Facility (the "Restructured Facility"), outstanding amounts under
the  Working Capital Facility were transferred to the Acquisition
Facility,  the  Working  Capital Facility  was  canceled  and  no
additional   borrowings  are  permitted  under  the   Acquisition
Facility.   The  Restructured Facility and the Overline  Facility
require  total  principal  payments of at  least  $40,000,000  by
January  2,  1997, at which time the availability  of  additional
working  capital borrowings under the Overline Facility  declines
to  $10,000,000.   Outstanding  amounts  under  the  Restructured
Facility  and  the  Overline Facility are due on  July  1,  1997.
Interest  on  loans  under  the  Restructured  Facility  and  the
Overline Facility will accrue at the agent bank's prime rate plus
1.5% and 2.0%, respectively, payable monthly in arrears.

The  Overline  Facility prohibits borrowings for  purposes  other
than working capital requirements, requires compliance with other
financial   covenants   and  imposes   limitations   on   certain
investments, dispositions of assets, additional indebtedness  and
capital  expenditures.  As collateral for the loans, the  Company
has  granted  a  security interest in substantially  all  of  its
assets,   including  substantially  all  of  its  trade  accounts
receivable and contract rights, and has provided a guaranty from,
and  pledged  the  common  stock of,  substantially  all  of  the
Company's  subsidiaries.   The Company has  also  granted  common
stock purchase warrants to the lenders entitling them to purchase
at  par  value  (over a vesting period) up to  5%  of  its  fully
diluted  common stock.  A portion of the warrants may be canceled
by repayment of certain loan principal amounts by certain dates.







                  COASTAL PHYSICIAN GROUP, INC.
             MANAGEMENT'S DISCUSSION AND ANALYSIS OF
          FINANCIAL CONDITION AND RESULTS OF OPERATIONS


INTRODUCTION

The  following discussion provides an assessment of the Company's
results  of  operations,  liquidity and  capital  resources,  and
trends and uncertainties, and should be read in conjunction  with
the  consolidated financial statements of the Company  and  notes
thereto included elsewhere in this document.

RESULTS OF OPERATIONS

FIRST  QUARTER ENDED MARCH 31, 1996 COMPARED TO THE FIRST QUARTER
ENDED MARCH 31, 1995.

Net  operating revenue ("operating revenue") decreased 26.5%  for
the  first  quarter of 1996 to $152,734,000 from $207,859,000  in
the first quarter of 1995.  The decrease in operating revenue due
to  dispositions completed since the first quarter  of  1995  for
which  prior periods' results were not restated was approximately
$54,349,000  or 26.1%.  This decrease was primarily  due  to  the
sale of 47 of the Company's south Florida clinics on November 30,
1995.   The  increase  in operating revenue due  to  acquisitions
completed  since  the  first quarter  of  1995  for  which  prior
periods'  results were not restated was approximately $11,036,000
or  5.3%.   This  increase was primarily due to the  purchase  of
Better  Health  Plan,  Inc. ("BHP") on May  5,  1995.   Operating
revenue  not  related to disposed or acquired entities  decreased
approximately  $11,812,000  or 5.7%.  Higher  contract  attrition
rates and less new business development in the Company's hospital-
based  contract management division were the primary  factors  in
lower  operating revenue in the first quarter of 1996 as compared
to  the  first  quarter of 1995 when disposition and acquisition-
related revenues are excluded.

Operating  expenses decreased 17.2% to $162,643,000 in the  first
quarter  of 1996 from $196,479,000 in the first quarter of  1995.
The  net  decrease in operating expenses due to dispositions  and
acquisitions completed since the first quarter of 1995 for  which
prior  periods'  results  were  not  restated  was  approximately
$38,746,000 or 19.7%.  Operating expenses not related to disposed
or  acquired entities increased approximately $4,910,000 or 2.5%.
This  increase  is  primarily  a  result  of  increased  expenses
associated with the growth in the number of enrollees in each  of
the Company's existing health maintenance organizations ("HMO's")
in   North   Carolina  and  Florida,  increased  investments   in
information  technology,  and reduced operating  margins  in  the
hospital-based  contract management and billing  and  collections
business.   Higher  contract attrition  and  lower  new  business
development   (as   discussed  above),   and   higher   physician
compensation   expense  and  the  continued  adverse   trend   in
collection experience, contributed to the variance between  these
quarters.

The changes in operating revenue and operating expenses described
above  resulted in an operating loss of $9,909,000 for the  first
quarter  of 1996, compared to operating income of $11,380,000  in
the first quarter of 1995.

Other  expenses increased 91.5% or $870,000 in the first  quarter
of  1996  to  $1,821,000  as compared to $951,000  in  the  first
quarter  of  1995.  An increase in  interest expense of  $938,000
was  the  primary  component  of the change  in  other  expenses.
Increased  interest  expense reflects  additional  borrowings  at
higher   average  interest  rates  required  primarily  to   fund
operating  activities.  Borrowings for operating activities  were
at higher levels during the first quarter of 1996 compared to the
same period in 1995 due primarily to operating losses.

The  provision  for income taxes decreased to $0  for  the  first
quarter  of  1996  from an expense of $4,062,000  for  the  first
quarter of 1995.  The Company expects to record no tax expense or
benefit until the Company recognizes profits in the future.

Overall,  the Company incurred a net loss of $11,730,000  in  the
first quarter of 1996 as compared to net income of $6,367,000  in
the first quarter of 1995 for the reasons discussed above.

Weighted   average   shares  outstanding  increased   1.1%   from
23,539,000  shares  in the first quarter of  1995  to  23,791,000
shares  in  the first quarter of 1996 primarily as  a  result  of
shares issued in connection with the exercise of stock options.

LIQUIDITY AND CAPITAL RESOURCES

Compared  to the prior year period, the Company has significantly
increased its borrowings under the Senior Credit Facility.  As of
March 31, 1996 borrowings under the Working Capital Facility were
$45,875,000 compared to borrowings of $28,500,000 as of March 31,
1995.   This increase resulted primarily from borrowings to  fund
operating  activities during the period between  the  two  dates.
Net  cash used in operating activities for the three months ended
March  31, 1996 was $10,728,000 as compared to net cash  provided
by operating activities for the three months ended March 31, 1995
of  $4,868,000.  Operating losses, increases in days in  accounts
receivable  and  required capital to fund the Company's  start-up
HMO  and  prepaid health services plan ("PHSP") in North Carolina
and New York have contributed to the negative operating cash flow
for  the three months ended March 31, 1996.  Borrowings under the
Acquisition   Facility   also   increased   significantly    from
$27,457,000 as of March 31, 1995 to $36,625,000 as of  March  31,
1996.   The  largest  component of this  increase  resulted  from
borrowings  to purchase BHP on May 5, 1995, and other  purchases,
net  of paydowns resulting from the divestiture of certain  south
Florida clinic operations on November 30, 1995.

The  Company  expects  to  satisfy its  anticipated  demands  and
commitments  for  cash  in the next twelve  months  from  amounts
available  under  its  Overline Facility, other  means  described
below  and  cash  generated  from  operations.   The  Company  is
implementing  a  management action plan and has  entered  into  a
contract  with  a  specialized unit of Price  Waterhouse  LLP  to
assist  the  Company in implementing the plan under  which  named
representatives of Price Waterhouse LLP have been  designated  as
plan  managers.   The  plan  managers  have  broad  authority  to
implement   the  plan  and  affect  operation  of  the  Company's
businesses,  and report directly to a special committee  composed
of  the  independent  members of the  Board  of  Directors.   The
management  action  plan requires review of all  aspects  of  the
Company's  business units (beginning with the contract management
and  billing  operations) and the implementation  of  actions  to
improve    cash    flow   characteristics,   profitability    and
contributions  to the Company's overall financial  and  strategic
objectives.   The  primary objectives of  these  actions  are  to
generate  increased cash flow to repay debt and  to  improve  the
Company's financial results.  If the Company is unable to achieve
these  objectives, it will likely experience a material  decrease
in liquidity, thus increasing its reliance on financing under the
Overline  Facility and decreasing the likelihood of  cancellation
of part of the warrants.

In   addition   to   restructuring  its  credit  facilities   and
implementation of a management action plan, the Company  recently
engaged  an  investment banker to assist in  the  exploration  of
potential  strategic  alternatives for optimizing  equity  value,
providing    additional   liquidity,   meeting   debt   repayment
obligations under the Restructured Facility and Overline Facility
on  January 2, 1997 and refinancing of the Restructured  Facility
and  Overline Facility before July 1997.  The investment  banker,
the  plan  manager,  as  well as other outside  consultants,  are
expected to advise the Company as to possible actions that  could
include  the  sale,  divestiture or spin off of  subsidiaries  or
operating divisions, the pursuit of asset-based or other new debt
financing,  potential equity offerings, or  some  combination  of
such alternatives.  Management currently anticipates that it will
be  necessary to sell certain of the Company's assets in order to
repay  the  $40,000,000 due under the Restructured  Facility  and
Overline Facility on January 2, 1997.

TRENDS AND UNCERTAINTIES

The Company experienced revenue declines in the first quarter  of
1996  as  compared  to the first quarter of 1995  when  excluding
revenues  related  to recent dispositions and acquisitions.   The
primary   reasons  behind  this  trend  include  higher  contract
attrition  and  lower new business development in  the  hospital-
based contract management division.  In response to these issues,
the  Company has recently reorganized the management team in this
division.

The  Company experienced lower operating margins during the first
quarter  of  1996  compared to the first quarter  of  1995.   The
operating  margin  for  the  quarter ended  March  31,  1996  was
negative 6.5% versus a positive 5.5% for the same period  in  the
prior year.  These lower operating margins were primarily due  to
increased    allowances   for   contractual    adjustments    and
uncollectibles  and  higher physician  compensation  expenses  as
compared  to  revenues in the hospital-based contract  management
division.

The   Company   operates   in   an  industry   characterized   by
consolidation  and combination led by a number  of  major  health
care  companies.   The  Company completed  numerous  acquisitions
during 1994 and 1995, but is now directing its primary efforts to
improvements   in  existing  operations  with  reduced   activity
relating  to potential acquisitions.  This change in strategy  is
due  to  the deterioration in revenue growth, increases in  costs
and  the  associated operating losses incurred in  the  Company's
traditional  lines  of business, as well as the  relative  rising
cost  of, and potential limited access to, capital necessary  for
acquisitions.

The  Company  is  continuing to incur substantial  expansion  and
operating  costs in its start-up health plans in  North  Carolina
and  New  York  and  in  its established HMO  in  north  Florida.
Profitable   future  results  for  these  entities  are   largely
dependent  on  successful regulatory approval for expansion  into
new  markets.  These approval processes, which are the domain  of
the  respective state (and in some cases, local) regulators,  can
increasingly  be  characterized  as  evolving  and  difficult  to
precisely predict.  This raises the prospect of potential  delays
in  obtaining  the  desired approvals on  a  timely  basis.   The
Company  will  continue to closely monitor developments  in  this
area.

The  Company  believes successful competition in the health  care
industry  will  increasingly  require  sophisticated  information
systems to rapidly provide a broad range of data related to  both
clinical and financial aspects of medical practice.  The  Company
has consequently committed to substantial costs over the next ten
years  in  information technology related to clinical  management
information systems, computerized billing operations, and its own
internal financial reporting systems.

If  the Company is unable to return to profitability and increase
cash  flow in the near term, it is possible that the Company  may
become unwilling or unable to continue to sustain the losses from
its   start-up  managed  care  operations  and  provider  network
development   in  North  Carolina,  to  continue  to   fund   its
significant investments in information technology, or to  provide
the  working  capital necessary to support growth in revenues  in
any  of  its existing lines of business.  The impairment  of  the
Company's  ability to continue these initiatives could limit  the
Company's  ability to realize its strategic and financial  goals,
as  well  as  lead to pursuit of possible divestiture of  managed
care  or  other selected assets.  As mentioned above, the Company
recently   engaged  an  investment  banker  to  assist   in   the
exploration of such potential actions.

Developments  in  the health care industry in  general  are  also
expected  to  impact  the  Company's  financial  performance  and
operating strategy.  These developments include trends of medical
expenses  in HMOs and other businesses where the risk  of  higher
medical  costs  is  assumed,  as  well  as  changing  levels   of
utilization    in    hospital-based   and   clinic    operations.
Additionally,  the  Company  will continue  to  monitor  proposed
changes  in  premiums  and levels of  reimbursement  from  payors
including HMOs, insurance companies, Medicare and Medicaid.

The  Company  will seek to continue to serve as a leading  health
care delivery system integrator in targeted markets.  The Company
believes   that  the  organization  of   physicians  in   various
arrangements  ranging from independent contractors  in  emergency
departments to employees in the Company's clinics is the  correct
strategy  as  providers shift to a more influential role  in  the
country's health care delivery system.

PART II - OTHER INFORMATION


ITEM 6. - Exhibits and Reports on Form 8-K

(a)Exhibits - None


(b)Reports on Form 8-K- None




                           SIGNATURES



Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the Registrant has duly caused this report to be signed  on
its behalf by the undersigned thereunto duly authorized.



                                   COASTAL PHYSICIAN GROUP, INC.
                                   (Registrant)



Date: June 10, 1996                By: /S/STEPHEN D. CORMAN
                                      Stephen D. Corman
                                        Director, Executive Vice
                                        President and Chief
                                        Financial Officer




Date: June 10, 1996                By: /S/TIMOTHY W. TROST
                                      Timothy W. Trost
                                        Vice President, Corporate
                                        Controller and Chief
                                        Accounting Officer



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
ACCOMPANYING BALANCE SHEET AS OF MARCH 31, 1996 AND STATEMENT OF OPERATIONS FOR
THE THREE MONTH PERIOD ENDED MARCH 31, 1996, AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                      19,314,000
<SECURITIES>                                 8,476,000
<RECEIVABLES>                              150,779,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                           208,686,000
<PP&E>                                      32,008,000
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                             315,222,000
<CURRENT-LIABILITIES>                       86,502,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       238,000
<OTHER-SE>                                 134,709,000
<TOTAL-LIABILITY-AND-EQUITY>               315,222,000
<SALES>                                    152,734,000
<TOTAL-REVENUES>                           152,734,000
<CGS>                                                0
<TOTAL-COSTS>                              162,643,000
<OTHER-EXPENSES>                             (282,000)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           2,103,000
<INCOME-PRETAX>                           (11,730,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (11,730,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (11,730,000)
<EPS-PRIMARY>                                   (0.49)
<EPS-DILUTED>                                        0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission